Raj Prabhakar Email & Phone Number | Experienced C-Level executive leader in gene, cell, viral vector and vaccines with 20 years global industry experience, recently in pediatric rare diseases and oncology - Public company senior executive experience in biotechnology with ex-vivo (autologous cell and gene) and in-vivo (AAV gene DNA and RNA therapy) development, with domain experience in pediatric rare disease, cardiology, oncology, oligonucleotides, immunotherapy, HSC stem cells and vaccines. Global experience in US, EMA, as well as Emerging Markets including China & Asia-Pacific. - Led banking syndicate diligence on behalf of Executive Leadership team that has raised over 1.1 Billion in institutional capital gross proceeds over last 6 years from leading Wall St. investment banks (Morgan Stanley, JP Morgan, Evercore, SVB Leerink, TD Cowen, BAML) - transactions ranging from 75 million to 300 million from leading healthcare hedge and mutual fund investors. - Manage external LRP, valuation, and banking, advisory relationships. - Operating experience in supply chain and manufacturing within GMP cell processing, viral vector, plasmid production and tangential areas within cell and gene therapy. Source, lead and negotiate manufacturing and supply agreements for drug substance, drug product, bioreactor and equipment, and facilities. - Experienced in in-and-out-licensing (IP) partnerships, fundraising and IR, advisory, private equity, venture capital, M&A. - Led all deal structuring through execution of multi-capsid AAV gene therapy license with REGENXBIO; - Secured License and development collaborations for China and Japan Territories, 2 largest markets for HCC liver cancer indication (negotiated all terms including milestones, royalties and development obligations); - Led all deal structuring through execution of 105 million M&A of PCT to Hitachi Chemical (Japan) for state of the art global cell processing facilities in complex 2-stage transactions; - Led all deal structuring through execution of complex License, JV and long term Supply agreement with Zhejiang Hisun for the Greater China Territory; - Led planning activities for US product launch, product marketing and pricing, patent protection & life cycle management; Specialties: biopharma product development from preclinical to P III. Managing timelines, budgets, licensing and partnerships, CMC, clinical development, and ongoing technology validation. Particular focus on joint Eastern-Western development projects - projects in Asia Pacific to utilize global clinical and development and manufacturing opportunities.

Raj Prabhakar

Experienced C-Level executive leader in gene, cell, viral vector and vaccines with 20 years global i...
New York, New York, United States

*50 free lookup(s) per month.

No credit card required.

Raj Prabhakar’s Email rprabhakar@rocketpharma.com

Raj Prabhakar’s Phone Numbers

Get RAJ’s Phone Number (For Free)

Social Media

Raj Prabhakar’s Location New York, New York, United States

Raj Prabhakar’s Current Industry Rocket Pharmaceuticals

Not the Raj Prabhakar you were looking for?

Find accurate emails & phone numbers for over 700M professionals.

Work Experience

Rocket Pharmaceuticals

Chief Business Officer & Senior Vice President

2017-10-01 00:00:00 - Present

Caladrius Biosciences

Senior Vice President Business Development

2015-08-01 00:00:00 - 2017-10-01 00:00:00

Celsion

Vice President Business Development

2004-01-01 00:00:00 - 2015-07-01 00:00:00

Path Global Vaccine Development Program

Senior Commercialization Officer, Vaccines

2014-02-01 00:00:00 - 2014-07-01 00:00:00

Protiveris

Director of Corporate Development

2002-07-01 00:00:00 - 2003-12-01 00:00:00

Osiris Therapeutics

Assistant to CEO, Director of Corporate Development

2002-01-01 00:00:00 - 2002-01-01 00:00:00

Harvard Business School

Student

1999-09-01 00:00:00 - 2001-06-01 00:00:00

Vertex Venture Management

Associate

2001-01-01 00:00:00 - 2001-01-01 00:00:00

Swander Pace Capital

Associate, Private Equity

1997-01-01 00:00:00 - 1999-01-01 00:00:00

Skills

No Skills Available

Languages

No Languages Available

FAQ About Raj Prabhakar

Raj Prabhakar is located at
New York, New York, United States

Raj Prabhakar is a Experienced C-Level executive leader in gene, cell, viral vector and vaccines with 20 years global industry experience, recently in pediatric rare diseases and oncology - Public company senior executive experience in biotechnology with ex-vivo (autologous cell and gene) and in-vivo (AAV gene DNA and RNA therapy) development, with domain experience in pediatric rare disease, cardiology, oncology, oligonucleotides, immunotherapy, HSC stem cells and vaccines. Global experience in US, EMA, as well as Emerging Markets including China & Asia-Pacific. - Led banking syndicate diligence on behalf of Executive Leadership team that has raised over 1.1 Billion in institutional capital gross proceeds over last 6 years from leading Wall St. investment banks (Morgan Stanley, JP Morgan, Evercore, SVB Leerink, TD Cowen, BAML) - transactions ranging from 75 million to 300 million from leading healthcare hedge and mutual fund investors. - Manage external LRP, valuation, and banking, advisory relationships. - Operating experience in supply chain and manufacturing within GMP cell processing, viral vector, plasmid production and tangential areas within cell and gene therapy. Source, lead and negotiate manufacturing and supply agreements for drug substance, drug product, bioreactor and equipment, and facilities. - Experienced in in-and-out-licensing (IP) partnerships, fundraising and IR, advisory, private equity, venture capital, M&A. - Led all deal structuring through execution of multi-capsid AAV gene therapy license with REGENXBIO; - Secured License and development collaborations for China and Japan Territories, 2 largest markets for HCC liver cancer indication (negotiated all terms including milestones, royalties and development obligations); - Led all deal structuring through execution of 105 million M&A of PCT to Hitachi Chemical (Japan) for state of the art global cell processing facilities in complex 2-stage transactions; - Led all deal structuring through execution of complex License, JV and long term Supply agreement with Zhejiang Hisun for the Greater China Territory; - Led planning activities for US product launch, product marketing and pricing, patent protection & life cycle management; Specialties: biopharma product development from preclinical to P III. Managing timelines, budgets, licensing and partnerships, CMC, clinical development, and ongoing technology validation. Particular focus on joint Eastern-Western development projects - projects in Asia Pacific to utilize global clinical and development and manufacturing opportunities.

Raj Prabhakar currently works in the Rocket Pharmaceuticals |

No Languages Available

Raj Prabhakar has prior
experience in the following industries:
Caladrius Biosciences | Celsion | Path Global Vaccine Development Program | Protiveris | Osiris Therapeutics | Harvard Business School | Vertex Venture Management | Swander Pace Capital

Raj Prabhakar has the following professional experience:
Rocket Pharmaceuticals | Caladrius Biosciences | Celsion | Path Global Vaccine Development Program | Protiveris | Osiris Therapeutics | Harvard Business School | Vertex Venture Management | Swander Pace Capital